Mode
Text Size
Log in / Sign up
Phase 3 Completed N=50 Randomized Treatment

Management of Post-Tonsillectomy Pain in Pediatric Patients

Pain, Postoperative · Tonsillar Hypertrophy · tonsillitis
Source: ClinicalTrials.gov NCT04551196 ↗
Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcomePrimary: Number of Participants With FLACC Pain Scores ≥7 From POD 1 Through POD 3 — 1; 1 participants
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

Single-center, randomized, open-label, non-inferiority treatment pilot study to evaluate the effectiveness of a combined acetaminophen and ibuprofen regimen for treatment of post-operative tonsillectomy pain in the pediatric population. 100 children undergoing tonsillectomy will be randomized to receive either a combined acetaminophen and ibuprofen regimen dosed every 6 hours or an alternating regimen of acetaminophen and ibuprofen dosed every 3 hours.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With FLACC Pain Scores ≥7 From POD 1 Through POD 3
1; 1
SECONDARY
Number of Participants With FLACC Pain Scores ≥7 on Each Individual POD 1, 3, and 7
1; 1
SECONDARY
Number of Participants With FLACC Pain Scores ≥7 From POD 1 Through POD 7
1; 1
SECONDARY
Number of Participants With Faces Pain Scores ≥8 on POD 1, 3, and 7
1; 1
SECONDARY
Number of Participants With Cumulative Faces Pain Scores ≥8 From POD 1 Through POD 7
3; 1
SECONDARY
Number of Participants With Rescue Medication Usage Through POD 3
3; 7
SECONDARY
Number of Participants With Rescue Medication Usage Through POD 7
1; 0
SECONDARY
Proportion of Subjects That Adhere to the Assigned Medication Regimen
25; 25
SECONDARY
Adverse Events
3; 3

Eligibility Criteria

Inclusion Criteria

  • 4 to 17 years of age at time of enrollment
  • Undergoing tonsillectomy with or without adenoidectomy
  • Able to provide informed consent from parent or legal guardian
  • Able to provide assent if subject is a minor of appropriate age

Exclusion Criteria

  • Allergy to acetaminophen or ibuprofen
  • Inability for study participant to cooperate with pain assessments
  • Known pregnancy
  • Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04551196). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search